CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

5.43

-0.13 (-2.34%)

At close: Feb 12, 2026, 4:00 PM EST

5.42

-0.01 (-0.18%)

After-hours: Feb 12, 2026, 7:55 PM EST

CytomX Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	920	81	104	106	283	303
Market Cap Growth	1333.08%	-22.37%	-1.80%	-62.58%	-6.69%	-19.81%
Enterprise Value	782	-26	-75	-70	69	7
Last Close Price	5.43	1.03	1.55	1.60	4.33	6.55
PE Ratio	22.67	2.53	-	-	-	-
Forward PE	-	-	16.30	-	-	-
PS Ratio	5.59	0.58	1.03	1.99	7.57	4.43
PB Ratio	8.35	-176.77	-2.19	-1.23	-615.53	-38.95
P/TBV Ratio	8.68	-	-	-	-	-
P/FCF Ratio	-	-	-	-	-	102.63
P/OCF Ratio	-	-	-	-	-	57.57
EV/Sales Ratio	6.88	-	-	-	1.84	0.11
EV/FCF Ratio	-	-	-	-	-	2.48
Debt / Equity Ratio	0.05	-20.58	-0.29	-0.21	-47.22	-3.20
Debt / EBITDA Ratio	0.20	0.31	-	-	-	-
Debt / FCF Ratio	-	-	-	-	-	8.43
Asset Turnover	0.77	0.86	0.44	0.18	0.11	0.20
Quick Ratio	3.54	1.21	1.14	1.51	3.93	4.65
Current Ratio	3.64	1.25	1.17	1.55	3.99	4.76
Return on Equity (ROE)	66.76%	-	-	-	-	-299.13%
Return on Assets (ROA)	9.78%	9.69%	-1.75%	-19.54%	-20.78%	-14.38%
Return on Capital Employed (ROCE)	19.80%	71.90%	-14.10%	-86.70%	-44.40%	-27.70%
Earnings Yield	3.05%	39.54%	-0.55%	-93.93%	-41.01%	-21.41%
FCF Yield	-7.86%	-107.36%	-54.78%	-106.42%	-42.70%	0.97%
Buyback Yield / Dilution	-41.04%	-14.82%	-12.27%	-2.48%	-39.01%	-1.79%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q